2008Journal of Medical ForumRequires access

Edaravone In Treatment of Acute Cerebral Infarction

Junfang Teng

Open publisher page 0 citations

Abstract

Objective To investigate the effectiveness and safety of edaravone for acute cerebral infarction.Methods Total 92 patients were randomly divided into two groups.Patients in each group were given Cytidine Diphos phate Choline 1.0g and Ginkgo Biloba Extract 20ml injection,Aspirin 100mg once per day.The treatment group was given Edaravone injection 30mg twice per day.The treatment was 14 days for both groups.The ESS was used to evaluate the recovery of neurological functions.Results ESS increased significantly in study group compared with that of control group after treatment.No serious drug reaction were found in two groups.Conclusion Edaravone injection is effective and safe in the treatment of acute cerebral infarction.

About this research paper

What this paper is about

Objective To investigate the effectiveness and safety of edaravone for acute cerebral infarction.Methods Total 92 patients were randomly divided into two groups.Patients in each group were given Cytidine Diphos phate Choline 1.0g and Ginkgo Biloba Extract 20ml injection,Aspirin 100mg once per day.The treatment group was given Edaravone injection 30mg twice per day.The treatment was 14 days for both groups.The ESS was used to evaluate the recovery of neurological functions.Results ESS increased significantly in study group compared with that of control group after treatment.No serious drug reaction were found in two groups.Conclusion Edaravone injection is effective and safe in the treatment of acute cerebral infarction.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effectiveness and safety of edaravone for acute cerebral infarction.Methods Total 92 patients were randomly divided into two groups.Patients in each group were given Cytidine Diphos phate Choline 1.0g and Ginkgo Biloba Extract 20ml injection,Aspirin 100mg once per day.The treatment group was given Edaravone injection 30mg twice per day.The treatment was 14 days for both groups.The ESS was used to evaluate the recovery of neurological functions.Results ESS increased significantly in study group compared with that of control group after treatment.No serious drug reaction were found in two groups.Conclusion Edaravone injection is effective and safe in the treatment of acute cerebral infarction.

Key concepts: Edaravone, Medicine, Aspirin, Ginkgo biloba, Citicoline, Anesthesia, Cerebral infarction, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Edaravone In Treatment of Acute Cerebral Infarction — Research Paper | ScholarLens